Agios Pharmaceuticals | Kontanter Og Tilsvarende

Cash And Equivalent Endring Dato
AbbVie USD 18.07B 4.78B 2024-03
Agios Pharmaceuticals USD 118.76M 30.56M 2024-03
Alnylam Pharmaceuticals USD 681.88M 130.81M 2024-03
Amgen USD 9.71B 1.24B 2024-03
Arrowhead Research USD 127.7M 69.49M 2024-03
Astellas Pharma JPY 253.98B 80.02B 2023-12
AstraZeneca USD 7.84B 2B 2024-03
Bayer EUR 4.73B 1.18B 2024-03
Biogen USD 1.07B 24.5M 2024-03
BioMarin Pharmaceutical USD 747M 8.13M 2024-03
Bristol-Myers Squibb USD 9.33B 2.13B 2024-03
Daiichi Sankyo JPY 666.74B 75.97B 2023-12
Eli Lilly USD 2.46B 79.4M 2024-03
Exelixis USD 259.56M 137.3M 2024-03
Gilead Sciences USD 4.72B 3.71B 2024-03
GlaxoSmithKline GBP 2.79B 146M 2024-03
Incyte USD 3.35B 132.83M 2024-03
Ionis Pharmaceuticals USD 348.89M 50.38M 2024-03
Merck USD 5.58B 3.03B 2024-03
Moderna USD 2.05B 856M 2024-03
Novartis USD 9.47B 3.92B 2024-03
Novartis USD 9.47B 3.92B 2024-03
Pfizer USD 719M 2.43B 2024-03
Regeneron Pharmaceuticals USD 2.6B 13.64B 2024-03
Roche Holding CHF 5.38B 1.66B 2023-12
Sarepta Therapeutics USD 427.29M 114.64M 2024-03
Vertex Pharmaceuticals USD 9.16B 1.95B 2024-03



Agios Pharmaceuticals Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.